Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Fennec Pharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +3 vs. Q2 2022
- Shares held
- 11.4M
- +86.1K (+0.8%) vs. Q2 2022
- Total value
- $92.1M
- +$28.9M (+45.8%) vs. Q2 2022
- New holders
- 7
- 4 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 90 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.8M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.6M |
| Q2 2024 | 64 | $87.7M |
| Q1 2024 | 65 | $161.1M |
| Q4 2023 | 56 | $168.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $49.9M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $89.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 14 | $0 | 0.00% | −259−94.9% | Reduced |
| JPMorgan Chase & Co | 70 | $1.00K | 0.00% | −7,665−99.1% | Reduced |
| FMR LLC | 112 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 139 | $1.00K | 0.00% | +139 | New |
| BNP Paribas Arbitrage, SA | 170 | $1.38K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,620 | $21.0K | 0.00% | −2,341−47.2% | Reduced |
| UBS Group AG | 3,099 | $26.0K | 0.00% | +3,035+4,742.2% | Added |
| Tower Research Capital LLC (TRC) | 3,611 | $29.0K | 0.00% | −366−9.2% | Reduced |
| Ancora Advisors, LLC | 7,245 | $59.0K | 0.00% | +1,245+20.8% | Added |
| Advisor Group Holdings, Inc. | 11,110 | $90.0K | 0.00% | −110−1.0% | Reduced |
| Jane Street Group, LLC | 14,507 | $118.0K | 0.00% | +14,507 | New |
| Group One Trading, L.P. | 14,924 | $121.0K | 0.00% | +14,924 | New |
| Citadel Advisors LLC | 15,676 | $127.0K | 0.00% | +15,676 | New |
| Geode Capital Management, LLC | 19,507 | $158.0K | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 25,000 | $202.0K | 0.00% | 00.0% | Unchanged |
| Jefferies Group LLC | 34,539 | $279.8K | 0.01% | +34,539 | New |
| Morgan Stanley | 36,062 | $292.0K | 0.00% | −4,279−10.6% | Reduced |
| Hartford Financial Management Inc. | 39,848 | $323.0K | 0.09% | +5,000+14.3% | Added |
| Valley Forge Investment Consultants Inc Adv | 40,000 | $324.0K | 0.18% | 00.0% | Unchanged |
| BlackRock Inc. | 49,367 | $399.0K | 0.00% | −2,002−3.9% | Reduced |
| Tamar Securities, LLC | 53,475 | $433.0K | 0.14% | 00.0% | Unchanged |
| Tamarack Advisers, LP | 175,000 | $1.42M | 0.84% | +175,000 | New |
| EAM Investors, LLC | 176,820 | $1.43M | 0.31% | +176,820 | New |
| Harbert Fund Advisors, Inc. | 189,750 | $1.54M | 1.23% | 00.0% | Unchanged |
| Millennium Management LLC | 249,337 | $2.02M | 0.00% | +11,945+5.0% | Added |
| 683 Capital Management, LLC | 384,824 | $3.12M | 0.25% | −40,514−9.5% | Reduced |
| DG Capital Management, LLC | 1,005,101 | $8.14M | 3.75% | −205,537−17.0% | Reduced |
| Solas Capital Management, LLC | 1,131,167 | $9.16M | 5.59% | −42,349−3.6% | Reduced |
| Avoro Capital Advisors LLC | 1,200,000 | $9.72M | 0.18% | 00.0% | Unchanged |
| Sonic Fund II, L.P. | 2,407,357 | $19.5M | 13.24% | 00.0% | Unchanged |
| Southpoint Capital Advisors LP | 4,077,214 | $33.0M | 0.89% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −49,075−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,029−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,177−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −61−100.0% | Sold out |